Disclaimer: This article is for general information only and does not replace individual medical advice. Always speak with a qualified healthcare professional before starting, stopping, or changing any medication.
If you are over 30 and have been told your blood pressure is “a bit high,” you are not alone. High blood pressure is one of Australia’s most common long-term conditions. The problem is that it rarely causes obvious symptoms — yet it silently damages your heart, brain, kidneys, and blood vessels. It increases your risk of heart attack, stroke, heart failure, and kidney disease.
As a doctor, I regularly hear the same concerns from patients: “I don’t want to start a medicine that gives me a dry cough.” “Will I have to give up grapefruit?” “Will the tablets make me dizzy or cost too much?” These are real, understandable worries. But what if there were a modern blood pressure medicine that specifically addresses many of these fears?
Telmisartan belongs to a class of medicines called angiotensin II receptor blockers (ARBs). It is a once-daily treatment used to lower high blood pressure and protect the heart and kidneys. In Australia, it is available on the Pharmaceutical Benefits Scheme (PBS) under brand names such as Micardis, Micardis Plus, Pritor, and various generic versions.
Unlike older ACE inhibitors such as ramipril, perindopril, or enalapril, telmisartan blocks the action of angiotensin II at its receptor rather than reducing its production. This difference is important because it means telmisartan rarely causes the dry, hacking cough that makes many patients stop ACE inhibitors. It also provides smooth 24-hour blood pressure control with once-daily dosing, which is convenient for people who want a simple routine.
| Feature | Telmisartan (ARB) | ACE Inhibitors (e.g., ramipril, perindopril) | Calcium Channel Blockers (e.g., amlodipine) |
|---|---|---|---|
| Dry cough | Very rare — similar to placebo | Common — up to 1 in 5 patients | Rare |
| Grapefruit juice interaction | No clinically significant interaction | No clinically significant interaction | Yes — may increase drug levels and side effects |
| Effect on left ventricular hypertrophy | Evidence supports regression of thickened heart muscle | Evidence supports regression | Some evidence |
| Protection in diabetic kidney disease | Yes — recommended | Yes — recommended | Less evidence |
| Once-daily dosing | Yes — provides 24-hour control | Usually once daily | Usually once daily |
| PBS listed | Yes — generic available | Yes — generic available | Yes — generic available |
Many patients stop their blood pressure medicine because of a persistent, irritating dry cough caused by ACE inhibitors. This cough can disrupt sleep, cause throat irritation, and make treatment feel worse than the disease. Telmisartan works differently, so the risk of dry cough is very low — similar to placebo. If you have experienced an ACE inhibitor cough, telmisartan is often an excellent alternative.
Long-standing high blood pressure can make the heart muscle thicken, a condition called left ventricular hypertrophy (LVH). LVH increases the risk of heart failure, irregular heart rhythms, and cardiac death. Clinical studies have shown that ARBs, including telmisartan, can help reduce left ventricular mass, allowing the heart to pump more efficiently and reducing long-term strain. This is a major benefit for patients with a long history of hypertension.
If you have type 2 diabetes, you may worry that blood pressure medicines could affect your blood sugar control. Telmisartan is generally metabolically neutral and may even have a mild beneficial effect on insulin sensitivity because of its unique partial PPAR-gamma activity. It is also recommended for kidney protection in people with diabetes and high blood pressure or albuminuria. In clinical trials, telmisartan was well tolerated by diabetic patients and caused fewer cough-related problems than ACE inhibitors.
Grapefruit juice is a part of many Australian breakfasts, but it can interact dangerously with some blood pressure medicines, especially certain calcium channel blockers like felodipine or amlodipine. The good news is that telmisartan has no clinically significant grapefruit juice interaction. You do not need to avoid grapefruit while taking telmisartan, which is one less lifestyle change to worry about.
Low blood pressure (hypotension) can cause dizziness, fainting, or falls — a particular concern for older Australians. Telmisartan is generally smooth in action, and when started at a low dose (often 40 mg), the risk of problematic hypotension is low. Doctors will typically check your blood pressure after starting or changing the dose, and they may adjust the dose gradually. Staying hydrated and rising slowly from sitting can further reduce any risk of dizziness.
Some medications can cause a rebound effect or withdrawal syndrome when stopped suddenly. Telmisartan does not cause a specific withdrawal syndrome. However, stopping any blood pressure medicine can allow your blood pressure to rise again over time, which increases your cardiovascular risk. Never stop telmisartan without discussing it with your doctor. If a change is needed, your doctor will advise a safe plan.
In Australia, the safety of medicines is monitored by the Therapeutic Goods Administration (TGA). Telmisartan has been used for decades and has a well-established safety record. Most side effects are mild and temporary — such as headache, dizziness, fatigue, or gastrointestinal discomfort. Serious side effects are rare. If you experience any unexpected symptom, you or your doctor can report it to the TGA’s Adverse Event Management System. This reporting system helps keep medicines safe for all Australians.
Cost is a legitimate concern for people over 30 who may need lifelong treatment. Telmisartan is PBS-subsidised, which keeps the cost manageable for most Australians. Generic versions are available and have been shown to be bioequivalent to the original brand, meaning they work the same way. Cost-effectiveness studies have shown that controlling blood pressure with ARBs like telmisartan can reduce hospitalisations, strokes, and heart attacks, ultimately saving patients and the healthcare system money in the long run.
| Clinical Topic | What You Need to Know |
|---|---|
| Cough vs ACE inhibitors | Telmisartan rarely causes dry cough — ideal if an ACE inhibitor cough made you stop treatment. |
| Left ventricular hypertrophy | May help reduce thickened heart muscle caused by high blood pressure. |
| Side effects in diabetics | Well tolerated; may improve insulin sensitivity; protects kidney function. |
| Grapefruit juice | No clinically significant interaction — you can continue enjoying grapefruit. |
| Hypotension risk | Low when started at the right dose and adjusted gradually; avoid dehydration. |
| Withdrawal symptoms | No true withdrawal syndrome, but stopping can allow blood pressure to rise again. |
| Adverse event reporting | TGA monitors safety; report any unexpected side effects to your doctor or the TGA. |
| Cost-effectiveness | PBS-subsidised; generic telmisartan is an affordable, long-term option. |
High blood pressure does not have to control your life. If you are over 30 and have elevated blood pressure, or if you have already been diagnosed but are unhappy with your current medicine due to cough, cost, or side effects, it is time to have a conversation with your GP.
Here is what you can do:
Your doctor can prescribe telmisartan if it is appropriate for you. With PBS subsidy and generic options, it is an affordable, once-daily treatment that offers powerful blood pressure control without the common cough of ACE inhibitors and without grapefruit restrictions.
Do not stop any current medication without medical advice. Instead, take the next step and ask your doctor whether telmisartan could be the right choice for your heart health.
This article is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or other qualified health provider with any questions you may have regarding a medical condition. Information about medicines may change; please consult the current approved Product Information and discuss with your prescriber.